Wyeth has a long history of innovation

Wyeth has been leading the way to a healthier world since the Civil War era, when John and Frank Wyeth opened a drug store in Philadelphia. Even from the first, Wyeth’s history has been one of innovation. John Wyeth and Brother developed unique methods of mass-producing quality medicines and then expanded into the new frontier of vaccines. During the past few decades, Wyeth has evolved into a research-driven pharmaceutical company focused on accelerating the pace of medical innovation around the world. Today, the people of Wyeth are united by a common mission and shared values, and dedicated to improving health.

Some Wyeth landmarks:

  • The development of the “compressed pill” or tablet and the first rotary tablet press
  • The pioneering development of an infant formula patterned after mother’s milk
  • The first orally active oestrogen, which became the pioneer product for oestrogen replacement therapy
  • The first firm to produce penicillin commercially
  • The first oral form of live trivalent poliovirus vaccine in the U.S.
  • The development of a heat-stable, freeze-dried vaccine and the bifurcated needle, which led to the worldwide eradication of smallpox
  • The first commercial synthesis of steroids for oral contraceptives
  • The first Haemophilus b conjugate vaccine licensed for use in infants in the U.S. for protection against bacterial meningitis
  • The first diphtheria/tetanus/acellular pertussis (DTaP) vaccine available in the U.S.
  • The first serotonin and norepinephrine reuptake inhibitor for effective treatment of depression
  • The first combination oestrogen/progestin hormone therapy in a single-tablet regimen
  • The first in a new class of rheumatoid arthritis drugs known as biologic response modifiers
  • The first albumin-free formulated recombinant factor VIII product
  • The first vaccine for the prevention of invasive pneumococcal disease in infants and toddlers
  • The first antidepressant indicated for generalized anxiety disorder
  • The first targeted chemotherapy agent using monoclonal antibody technology
  • The first to market an over-the-counter ibuprofen product
  • The first canine heartworm preventative that provides six months of continuous protection in one injectable dose
  • The first canine Lyme disease and Lyme combination vaccines
  • The first molecular cloned feline leukemia vaccine
  • The first modified-live canine parvovirus vaccine
  • The first West Nile virus vaccine for horses

For more information
go to: